Immunometabolomics provides a new perspective for studying systemic lupus erythematosus.

Wu, Yuxian; Zhao, Mengpei; Gong, Na; Zhang, Feng; Chen, Wansheng; Liu, Yaoyang

Wu, Yuxian; Zhao, Mengpei; Gong, Na; Zhang, Feng; Chen, Wansheng; Liu, Yaoyang.

Afiliação

Wu Y; College of Basic Medicine, Naval Medical University, Shanghai, China.
Zhao M; Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China.
Gong N; College of Basic Medicine, Naval Medical University, Shanghai, China.
Zhang F; Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China.
Chen W; Department of Pharmacy, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: chenwansheng@smmu.edu.cn.
Liu Y; Department of Rheumatology and Immunology, Changzheng Hospital, Naval Medical University, Shanghai, China. Electronic address: liuyaoyang000@163.com.

Int Immunopharmacol ; 118: 109946, 2023 May.

Article em En | MEDLINE | ID: mdl-36931174

Assuntos

Lúpus Eritematoso Sistêmico; Humanos; Biomarcadores/metabolismo; Diferenciação Celular

Palavras-chave

Biomarker; Diagnosis; Immunometabolomics; Metabolomics; SLE; Treatment

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Lúpus Eritematoso Sistêmico Limite: Humans Idioma: En Revista: Int Immunopharmacol Assunto da revista: ALERGIA E IMUNOLOGIA / FARMACOLOGIA Ano de publicação: 2023 Tipo de documento: Article País de afiliação: China

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google